Yes, many of the European countries pay far less. I know a little bit about Australia, for instance, but you're talking about there being one door into that country. It is the front-end regulator, and it sets fees based on negotiations to access the market in Australia as a whole. Here in Canada, we regulate the health and safety of a drug, but there are multiple buyers, as you know.
On May 9th, 2017. See this statement in context.